Kent Abrahamson

AbbVie
Director, Combination Product Development
Kent Abrahamson is a Director of Combination Product and Device Development at AbbVie. He has over 30 years’ experience in medical device, pharmaceutical, and combination product development. Kent has developed and launched a large range of drug delivery systems. He has designed general use, pain management, and ambulatory infusion pumps. He led development activities and launched a proprietary pharmaceutical and led the initial development work on the drug eluting stent at Abbott which formed the basis for the product on-market today. He has many device and pharmaceutical patents and has published on the topics of combination product reliability and platform drug delivery devices. Most recently, Kent defined, created, and led the Systems Engineering, Product Engineering, and Engineering Test & Analysis teams at AbbVie. These teams contributed to the development of many combination products that include the Skyrizi auto injector, the Skyrizi on-body infuser, and the electromechanical infusion pump Vyalev. Kent is an active member of the AAMI and ISPE Combination Product working groups. He has a BS and MS in Mechanical Engineering and is a registered Professional Engineer.